Jixian Tang

Title: Jixian Tang: Innovator in Hepatitis B Research

Introduction

Jixian Tang is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of medical research, particularly in the development of antibodies for the treatment of hepatitis B virus (HBV) infections. His innovative work has the potential to improve the lives of many individuals affected by this disease.

Latest Patents

Jixian Tang holds a patent for an "Anti-hepatitis B virus antibody and uses thereof." This patent discloses antibodies to the anti-hepatitis B surface antigen (HBsAg), especially humanized antibodies. The invention includes nucleic acid molecules encoding these antibodies, methods for preparing them, and pharmaceutical compositions containing them. The antibodies exhibit higher affinity for HBsAg at neutral pH compared to acidic pH, significantly enhancing virus clearance efficiency and prolonging the virus inhibition time. These antibodies can be utilized for preventing and treating HBV infections or related diseases, neutralizing HBV virulence, reducing serum levels of HBV DNA and/or HBsAg, and activating the humoral immune response in chronic HBV patients.

Career Highlights

Throughout his career, Jixian Tang has worked with esteemed institutions such as Xiamen University and Yang Sheng Tang Company Limited. His research has focused on developing effective treatments for HBV, showcasing his dedication to advancing medical science.

Collaborations

Jixian Tang has collaborated with notable colleagues, including Wenxin Luo and Can Wen. These partnerships have contributed to the success of his research and the development of innovative solutions for HBV treatment.

Conclusion

Jixian Tang's work in the field of hepatitis B research exemplifies the impact of innovation in medicine. His patented antibodies offer promising avenues for the prevention and treatment of HBV infections, highlighting the importance of continued research and collaboration in this critical area of healthcare.